Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q2 2016
|
ABUS |
|
Phase 2 Results |
Infectious Disease |
None |
|
07/01/2016
|
INSY |
|
PDUFA |
Oncology |
None |
|
07/19/2016
|
VRX |
|
PDUFA |
Other |
None |
|
07/24/2016
|
OCUL |
|
PDUFA |
Opthamology |
None |
|
Q3 2016
|
GNCA |
|
Phase 2b Results |
Infectious Disease |
None |
|
Q3 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q3 2016
|
ACRS |
|
Phase 3 Results |
Other |
None |
|
Q3 2016
|
ACRS |
|
Phase 2 Results |
Other |
None |
|
08/17/2016
|
PTLA |
|
PDUFA |
Other |
Accelerated Approval, Breakthrough Therapy |
|
Q3 2016
|
RPRX |
|
Phase 2 Results |
Endocrine |
None |
|